RxDoctor Payments Data

Christine Childs, MD

Psychiatry · Winston Salem, NCNPI 1952339236

Payments from drug & device makers

$7,851in general payments, 2019–2025

Across 458 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Neurocrine Biosciences, Inc.$835
  • Takeda Pharmaceuticals U.S.A., Inc.$694
  • Otsuka America Pharmaceutical, Inc.$694
  • Teva Pharmaceuticals USA, Inc.$626
  • plus $3K from 19 others

What the payments were for

  • Food & beverage$7,69298%
  • Education$1582%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,851 in reported general payments places this provider in the 90th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$17,654
Medicare patients
84
Services billed
199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate23$18,892
Bupropion XlBupropion Hcl285$5,898
Aripiprazole91$5,727
Clomipramine Hcl15$5,413
Venlafaxine Hcl ErVenlafaxine Hcl124$3,457
Carbamazepine38$3,179
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine82$2,943
Lamotrigine159$2,804
Duloxetine Hcl158$2,723
Trazodone Hcl164$2,587
Escitalopram Oxalate185$2,353
Lisdexamfetamine Dimesylate11$2,170
Oxcarbazepine28$2,137
Buspirone Hcl83$2,018
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$1,797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$502$18,89223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →